Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Alector, Inc.ALEC · Entity 6051 | Chief Medical Officer | August 09, 2021 | August 11, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Alector, Inc.
Report date August 09, 2021 · Filed August 11, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 234,319 |
Ending reported balance
After 2021-08-09 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2021-08-09 · Exercise / conversion · Acquired 9,691 · Balance 244,010 Row 2 · 2021-08-09 · Exercise / conversion · Acquired 8,734 · Balance 252,744 Row 3 · 2021-08-09 · Exercise / conversion · Acquired 4,525 · Balance 257,269 Row 4 · 2021-08-09 · Sale · Disposed 22,650 · Balance 234,619 F1: The sales reported by the reporting person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.71 to $27.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. Row 5 · 2021-08-09 · Sale · Disposed 300 · Balance 234,319 F1: The sales reported by the reporting person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020. F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.71 to $27.83, inclusive. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.16 · Expires 2028-07-02 | Direct | 81,000 |
Reported balance
After 2021-08-09 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2021-08-09 · Exercise / conversion · Disposed 9,691 · Balance 81,000 F4: Shares subject to the option vest in 48 equal monthly installments beginning on August 2, 2018. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.14 · Expires 2028-11-06 | Direct | 31,250 |
Reported balance
After 2021-08-09 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2021-08-09 · Exercise / conversion · Disposed 8,734 · Balance 31,250 F5: One-fourth of the total number of shares subject to the option grant vested on November 1, 2019, and an additional 1/48th of the shares subject vest monthly thereafter. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $17.15 · Expires 2029-11-06 | Direct | 84,450 |
Reported balance
After 2021-08-09 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2021-08-09 · Exercise / conversion · Disposed 4,525 · Balance 84,450 F6: Shares subject to the option vest in 48 equal monthly installments beginning on December 6, 2019. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported by the reporting person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.71 to $27.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.71 to $27.83, inclusive.
F4: Shares subject to the option vest in 48 equal monthly installments beginning on August 2, 2018.
F5: One-fourth of the total number of shares subject to the option grant vested on November 1, 2019, and an additional 1/48th of the shares subject vest monthly thereafter.
F6: Shares subject to the option vest in 48 equal monthly installments beginning on December 6, 2019.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 18, 2021 Filed May 20, 2021 21:20 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,900 | $0.00 Strike: $8.16 | $0.00 |
DisclosureSEC source: 0001209191-21-034508 · doc4.xml · derivative · entry 4 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,566 Underlying: Common Stock · 2,900 shares Expires 2028-07-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: One forty-eighth (1/48th) of the shares subject to the option vested on August 2, 2018, and one forty-eighth (1/48th) of the shares subject to the option vest monthly thereafter. Read SEC document |
| May 18, 2021 Filed May 20, 2021 21:20 UTC | Alector, Inc. ALEC · Entity 6051 | SaleCommon Stock | 4,200 | $18.04 | $75,786.06 |
DisclosureSEC source: 0001209191-21-034508 · doc4.xml · nonDerivative · entry 3 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 273,719 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.09, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 18, 2021 Filed May 20, 2021 21:20 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionCommon Stock | 1,300 | $10.14 | $13,182.00 |
DisclosureSEC source: 0001209191-21-034508 · doc4.xml · nonDerivative · entry 2 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 277,919 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 18, 2021 Filed May 20, 2021 21:20 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionCommon Stock | 2,900 | $8.16 | $23,664.00 |
DisclosureSEC source: 0001209191-21-034508 · doc4.xml · nonDerivative · entry 1 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,619 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 07, 2021 Filed May 11, 2021 22:43 UTC | Alector, Inc. ALEC · Entity 6051 | GrantCommon Stock | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-031846 · doc4.xml · nonDerivative · entry 1 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 273,719 F1 · shares: The reported shares are represented by performance share units, or PSUs. Fifty percent of the award will be earned if the Issuer's average closing stock price is $30 per share for 40 consecutive trading days and an additional fifty percent will be earned if the average closing stock price is $40 per share for 40 consecutive trading days. Upon attainment of the performance metrics, the shares vest in four equal quarterly installments beginning on the first vesting date as set forth in the PSU award agreement. Read SEC document |
| April 07, 2021 Filed Apr 9, 2021 00:18 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,125 | $0.00 Strike: $17.15 | $0.00 |
DisclosureSEC source: 0001209191-21-026167 · doc4.xml · derivative · entry 8 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,875 Underlying: Common Stock · 3,125 shares Expires 2029-11-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The shares subject to this option vest in 48 equal monthly installments beginning on December 6, 2019. Read SEC document |
| April 07, 2021 Filed Apr 9, 2021 00:18 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,083 | $0.00 Strike: $10.14 | $0.00 |
DisclosureSEC source: 0001209191-21-026167 · doc4.xml · derivative · entry 7 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,251 Underlying: Common Stock · 2,083 shares Expires 2028-11-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vested on November 1, 2019 and one forty-eighth (1/48th) of the shares vest monthly thereafter. Read SEC document |
| April 07, 2021 Filed Apr 9, 2021 00:18 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 17,092 | $0.00 Strike: $8.16 | $0.00 |
DisclosureSEC source: 0001209191-21-026167 · doc4.xml · derivative · entry 6 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,466 Underlying: Common Stock · 17,092 shares Expires 2028-07-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: One forty-eighth (1/48th) of the shares subject to the option vested on August 2, 2018, and one forty-eighth (1/48th) of the shares subject to the option vest monthly thereafter. Read SEC document |
| April 07, 2021 Filed Apr 9, 2021 00:18 UTC | Alector, Inc. ALEC · Entity 6051 | SaleCommon Stock | 45 | $19.83 | $892.35 |
DisclosureSEC source: 0001209191-21-026167 · doc4.xml · nonDerivative · entry 5 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,719 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.83 to $19.83, inclusive. Read SEC document |
| April 07, 2021 Filed Apr 9, 2021 00:18 UTC | Alector, Inc. ALEC · Entity 6051 | SaleCommon Stock | 22,255 | $19.19 | $427,158.02 |
DisclosureSEC source: 0001209191-21-026167 · doc4.xml · nonDerivative · entry 4 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,764 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.81 to $19.80, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| April 07, 2021 Filed Apr 9, 2021 00:18 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionCommon Stock | 3,125 | $17.15 | $53,593.75 |
DisclosureSEC source: 0001209191-21-026167 · doc4.xml · nonDerivative · entry 3 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236,019 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 07, 2021 Filed Apr 9, 2021 00:18 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionCommon Stock | 2,083 | $10.14 | $21,121.62 |
DisclosureSEC source: 0001209191-21-026167 · doc4.xml · nonDerivative · entry 2 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,894 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 07, 2021 Filed Apr 9, 2021 00:18 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionCommon Stock | 17,092 | $8.16 | $139,470.72 |
DisclosureSEC source: 0001209191-21-026167 · doc4.xml · nonDerivative · entry 1 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,811 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 23, 2021 Filed Mar 24, 2021 20:36 UTC | Alector, Inc. ALEC · Entity 6051 | SaleCommon Stock | 13,800 | $22.21 | $306,498.00 |
DisclosureSEC source: 0001209191-21-022851 · doc4.xml · nonDerivative · entry 5 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,719 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020. Read SEC document |
| March 23, 2021 Filed Mar 24, 2021 20:36 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionCommon Stock | 13,800 | $8.16 | $112,608.00 |
DisclosureSEC source: 0001209191-21-022851 · doc4.xml · nonDerivative · entry 4 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 227,519 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 22, 2021 Filed Mar 24, 2021 20:36 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 13,800 | $0.00 Strike: $8.16 | $0.00 |
DisclosureSEC source: 0001209191-21-022851 · doc4.xml · derivative · entry 7 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,558 Underlying: Common Stock · 13,800 shares Expires 2028-07-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: One forty-eighth (1/48th) of the shares subject to the option vested on August 2, 2018, and one forty-eighth (1/48th) of the shares subject to the option vest monthly thereafter. Read SEC document |
| March 22, 2021 Filed Mar 24, 2021 20:36 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $8.16 | $0.00 |
DisclosureSEC source: 0001209191-21-022851 · doc4.xml · derivative · entry 6 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,358 Underlying: Common Stock · 30,000 shares Expires 2028-07-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: One forty-eighth (1/48th) of the shares subject to the option vested on August 2, 2018, and one forty-eighth (1/48th) of the shares subject to the option vest monthly thereafter. Read SEC document |
| March 22, 2021 Filed Mar 24, 2021 20:36 UTC | Alector, Inc. ALEC · Entity 6051 | SaleCommon Stock | 5,510 | $23.55 | $129,774.28 |
DisclosureSEC source: 0001209191-21-022851 · doc4.xml · nonDerivative · entry 3 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,719 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.44 to $23.97, inclusive. Read SEC document |
| March 22, 2021 Filed Mar 24, 2021 20:36 UTC | Alector, Inc. ALEC · Entity 6051 | SaleCommon Stock | 24,490 | $22.85 | $559,601.40 |
DisclosureSEC source: 0001209191-21-022851 · doc4.xml · nonDerivative · entry 2 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,229 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $22.41 to $23.38 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| March 22, 2021 Filed Mar 24, 2021 20:36 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionCommon Stock | 30,000 | $8.16 | $244,800.00 |
DisclosureSEC source: 0001209191-21-022851 · doc4.xml · nonDerivative · entry 1 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 243,719 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 09, 2021 Filed Mar 10, 2021 23:29 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,083 | $0.00 Strike: $10.14 | $0.00 |
DisclosureSEC source: 0001209191-21-019607 · doc4.xml · derivative · entry 5 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,334 Underlying: Common Stock · 2,083 shares Expires 2028-11-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vested on November 1, 2019 and one forty-eighth (1/48th) of the shares vest monthly thereafter. Read SEC document |
| March 09, 2021 Filed Mar 10, 2021 23:29 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 17,092 | $0.00 Strike: $8.16 | $0.00 |
DisclosureSEC source: 0001209191-21-019607 · doc4.xml · derivative · entry 4 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,358 Underlying: Common Stock · 17,092 shares Expires 2028-07-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: One forty-eighth (1/48th) of the shares subject to the option vested on August 2, 2018, and one forty-eighth (1/48th) of the shares subject to the option vest monthly thereafter. Read SEC document |
| March 09, 2021 Filed Mar 10, 2021 23:29 UTC | Alector, Inc. ALEC · Entity 6051 | SaleCommon Stock | 19,175 | $18.12 | $347,404.98 |
DisclosureSEC source: 0001209191-21-019607 · doc4.xml · nonDerivative · entry 3 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,719 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 09, 2021 Filed Mar 10, 2021 23:29 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionCommon Stock | 2,083 | $10.14 | $21,121.62 |
DisclosureSEC source: 0001209191-21-019607 · doc4.xml · nonDerivative · entry 2 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,894 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 09, 2021 Filed Mar 10, 2021 23:29 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionCommon Stock | 17,092 | $8.16 | $139,470.72 |
DisclosureSEC source: 0001209191-21-019607 · doc4.xml · nonDerivative · entry 1 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,811 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:08 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,084 | $0.00 Strike: $10.14 | $0.00 |
DisclosureSEC source: 0001209191-21-009765 · doc4.xml · derivative · entry 5 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,417 Underlying: Common Stock · 2,084 shares Expires 2028-11-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vested on November 1, 2019 and one forty-eighth (1/48th) of the shares vest monthly thereafter. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:08 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 17,091 | $0.00 Strike: $8.16 | $0.00 |
DisclosureSEC source: 0001209191-21-009765 · doc4.xml · derivative · entry 4 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,450 Underlying: Common Stock · 17,091 shares Expires 2028-07-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: One forty-eighth (1/48th) of the shares subject to the option vested on August 2, 2018, and one forty-eighth (1/48th) of the shares subject to the option vest monthly thereafter. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:08 UTC | Alector, Inc. ALEC · Entity 6051 | SaleCommon Stock | 19,175 | $20.81 | $399,054.76 |
DisclosureSEC source: 0001209191-21-009765 · doc4.xml · nonDerivative · entry 3 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,719 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.45 to $21.05, inclusive. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:08 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionCommon Stock | 2,084 | $10.14 | $21,131.76 |
DisclosureSEC source: 0001209191-21-009765 · doc4.xml · nonDerivative · entry 2 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,894 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:08 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionCommon Stock | 17,091 | $8.16 | $139,462.56 |
DisclosureSEC source: 0001209191-21-009765 · doc4.xml · nonDerivative · entry 1 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,810 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 26, 2021 Filed Jan 27, 2021 23:53 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,166 | $0.00 Strike: $10.14 | $0.00 |
DisclosureSEC source: 0001209191-21-005750 · doc4.xml · derivative · entry 10 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,501 Underlying: Common Stock · 4,166 shares Expires 2028-11-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vested on November 1, 2019 and one forty-eighth (1/48th) of the shares vest monthly thereafter. Read SEC document |
| January 26, 2021 Filed Jan 27, 2021 23:53 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 23,142 | $0.00 Strike: $8.16 | $0.00 |
DisclosureSEC source: 0001209191-21-005750 · doc4.xml · derivative · entry 9 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,541 Underlying: Common Stock · 23,142 shares Expires 2028-07-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: One forty-eighth (1/48th) of the shares subject to the option vested on August 2, 2018, and one forty-eighth (1/48th) of the shares subject to the option vest monthly thereafter. Read SEC document |
| January 26, 2021 Filed Jan 27, 2021 23:53 UTC | Alector, Inc. ALEC · Entity 6051 | SaleCommon Stock | 27,308 | $18.00 | $491,544.00 |
DisclosureSEC source: 0001209191-21-005750 · doc4.xml · nonDerivative · entry 6 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,719 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.055, inclusive. Read SEC document |
| January 26, 2021 Filed Jan 27, 2021 23:53 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionCommon Stock | 4,166 | $10.14 | $42,243.24 |
DisclosureSEC source: 0001209191-21-005750 · doc4.xml · nonDerivative · entry 5 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 241,027 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 26, 2021 Filed Jan 27, 2021 23:53 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionCommon Stock | 23,142 | $8.16 | $188,838.72 |
DisclosureSEC source: 0001209191-21-005750 · doc4.xml · nonDerivative · entry 4 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236,861 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 25, 2021 Filed Jan 27, 2021 23:53 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,084 | $0.00 Strike: $10.14 | $0.00 |
DisclosureSEC source: 0001209191-21-005750 · doc4.xml · derivative · entry 8 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,667 Underlying: Common Stock · 2,084 shares Expires 2028-11-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vested on November 1, 2019 and one forty-eighth (1/48th) of the shares vest monthly thereafter. Read SEC document |
| January 25, 2021 Filed Jan 27, 2021 23:53 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 27,916 | $0.00 Strike: $8.16 | $0.00 |
DisclosureSEC source: 0001209191-21-005750 · doc4.xml · derivative · entry 7 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 257,683 Underlying: Common Stock · 27,916 shares Expires 2028-07-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: One forty-eighth (1/48th) of the shares subject to the option vested on August 2, 2018, and one forty-eighth (1/48th) of the shares subject to the option vest monthly thereafter. Read SEC document |
| January 25, 2021 Filed Jan 27, 2021 23:53 UTC | Alector, Inc. ALEC · Entity 6051 | SaleCommon Stock | 30,000 | $18.01 | $540,225.00 |
DisclosureSEC source: 0001209191-21-005750 · doc4.xml · nonDerivative · entry 3 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,719 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| January 25, 2021 Filed Jan 27, 2021 23:53 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionCommon Stock | 2,084 | $10.14 | $21,131.76 |
DisclosureSEC source: 0001209191-21-005750 · doc4.xml · nonDerivative · entry 2 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 243,719 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 25, 2021 Filed Jan 27, 2021 23:53 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionCommon Stock | 27,916 | $8.16 | $227,794.56 |
DisclosureSEC source: 0001209191-21-005750 · doc4.xml · nonDerivative · entry 1 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 241,635 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 20, 2021 Filed Jan 21, 2021 23:46 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,083 | $0.00 Strike: $10.14 | $0.00 |
DisclosureSEC source: 0001209191-21-004742 · doc4.xml · derivative · entry 10 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,751 Underlying: Common Stock · 2,083 shares Expires 2028-11-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vested on November 1, 2019 and one forty-eighth (1/48th) of the shares vest monthly thereafter. Read SEC document |
| January 20, 2021 Filed Jan 21, 2021 23:46 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 6,484 | $0.00 Strike: $8.16 | $0.00 |
DisclosureSEC source: 0001209191-21-004742 · doc4.xml · derivative · entry 9 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 285,599 Underlying: Common Stock · 6,484 shares Expires 2028-07-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: One forty-eighth (1/48th) of the shares subject to the option vested on August 2, 2018, and one forty-eighth (1/48th) of the shares subject to the option vest monthly thereafter. Read SEC document |
| January 20, 2021 Filed Jan 21, 2021 23:46 UTC | Alector, Inc. ALEC · Entity 6051 | SaleCommon Stock | 8,567 | $18.00 | $154,211.14 |
DisclosureSEC source: 0001209191-21-004742 · doc4.xml · nonDerivative · entry 6 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,719 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.01, inclusive. Read SEC document |
| January 20, 2021 Filed Jan 21, 2021 23:46 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionCommon Stock | 2,083 | $10.14 | $21,121.62 |
DisclosureSEC source: 0001209191-21-004742 · doc4.xml · nonDerivative · entry 5 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,286 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 20, 2021 Filed Jan 21, 2021 23:46 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionCommon Stock | 6,484 | $8.16 | $52,909.44 |
DisclosureSEC source: 0001209191-21-004742 · doc4.xml · nonDerivative · entry 4 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,203 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 23:46 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,083 | $0.00 Strike: $10.14 | $0.00 |
DisclosureSEC source: 0001209191-21-004742 · doc4.xml · derivative · entry 8 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,834 Underlying: Common Stock · 2,083 shares Expires 2028-11-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vested on November 1, 2019 and one forty-eighth (1/48th) of the shares vest monthly thereafter. Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 23:46 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 27,917 | $0.00 Strike: $8.16 | $0.00 |
DisclosureSEC source: 0001209191-21-004742 · doc4.xml · derivative · entry 7 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 292,083 Underlying: Common Stock · 27,917 shares Expires 2028-07-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: One forty-eighth (1/48th) of the shares subject to the option vested on August 2, 2018, and one forty-eighth (1/48th) of the shares subject to the option vest monthly thereafter. Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 23:46 UTC | Alector, Inc. ALEC · Entity 6051 | SaleCommon Stock | 30,000 | $18.12 | $543,552.00 |
DisclosureSEC source: 0001209191-21-004742 · doc4.xml · nonDerivative · entry 3 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,719 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 23:46 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionCommon Stock | 2,083 | $10.14 | $21,121.62 |
DisclosureSEC source: 0001209191-21-004742 · doc4.xml · nonDerivative · entry 2 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 243,719 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 23:46 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionCommon Stock | 27,917 | $8.16 | $227,802.72 |
DisclosureSEC source: 0001209191-21-004742 · doc4.xml · nonDerivative · entry 1 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 241,636 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.